Purchase of 100,000 shares at $0.92 per share.
Reporting Person Barry Richard · Officer Title President & CEO · Transaction Code P
Traded Sep 30, 2026 · Disclosed Oct 1, 2026
Source: SEC Form 4 · 0001437749-26-031654 · filed 2026-10-01 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "FILANA THERAPEUTICS, INC. (FLNA)." Disclosed 2026-10-01. https://desqlong.com/cards/0001437749-26-031654-2 (retrieved 2026-10-02).